Patent · US Active

Methods for rapidly treating severe hypoglycemia

US9018162B2 · kind B2 · utility

1Cited by
37References
17Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 14, 2013
Grant dateApr 28, 2015
Priority date
Expiry dateMar 14, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a method for treating or preventing hypoglycemia in a patient comprising administering an effective amount of a composition comprising a glucagon peptide which has been dried in a non-volatile buffer, and wherein the glucagon peptide has a pH memory that is about equal to the pH of the glucagon peptide in the non-volatile buffer, and an aprotic polar solvent, wherein the moisture content of the formulation is less than 5%, and wherein the dried glucagon peptide maintains the pH memory that is about equal to the pH of the glucagon peptide in the non-volatile buffer when the dried glucagon peptide is reconstituted in the aprotic polar solvent, wherein the patient has been diagnosed as having a blood glucose level between 0 mg/dL and less than 50 mg/dL or has an indication of impending hypoglycemia based on a blood glucose monitoring device before administration of the composition, and wherein the patient has a blood glucose level greater than 50 mg/dL to 180 mg/dL within 1 to 20 minutes after administration of the composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.